Treatment consists primarily of symptom relief and management of complications. For individuals with confirmed Covid-19 disease who are at high risk for a severe course, antiviral therapy may be appropriate. Such therapies are now available for outpatients who belong to specific risk groups. 
The most important measure to avoid severe courses of the disease remains vaccination.

The recommendation for healthcare professionals concerning early use of Covid-19 therapies as well as prophylaxis issued by the Swiss society for infectiolous disease can be found here: Kriterienliste der SSI (english).

For further information about dispensing, prescribing, ordering and accounting Covid-19 treatments that are available in Switzerland please consult the webpage of the FOPH